BioVie Inc is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107...
- MA confluence on pullback - High RS - High ADR - Higher lows in base - Biotech
All max achieved past history displayed. Forward in the future to 70$ today.
BioVie Inc. is a clinical-stage company pursuing the discovery, development, and commercialization of drug therapies for liver disease
This would should reverse ASAP keep a close eye on it for trend break or news